These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 21109120)
1. Erythropoietin receptor signaling mitigates renal dysfunction-associated heart failure by mechanisms unrelated to relief of anemia. Ogino A; Takemura G; Kawasaki M; Tsujimoto A; Kanamori H; Li L; Goto K; Maruyama R; Kawamura I; Takeyama T; Kawaguchi T; Watanabe T; Moriguchi Y; Saito H; Fujiwara T; Fujiwara H; Minatoguchi S J Am Coll Cardiol; 2010 Nov; 56(23):1949-58. PubMed ID: 21109120 [TBL] [Abstract][Full Text] [Related]
2. Asialoerythropoietin to protect the failing heart: is it possible to run with the hare and hunt with the hounds? van der Meer P; Lipsic E; van Veldhuisen DJ J Am Coll Cardiol; 2010 Nov; 56(23):1959-60. PubMed ID: 21109121 [No Abstract] [Full Text] [Related]
4. Asialoerythropoietin has strong renoprotective effects against ischemia-reperfusion injury in a murine model. Okada T; Sawada T; Kubota K Transplantation; 2007 Aug; 84(4):504-10. PubMed ID: 17713435 [TBL] [Abstract][Full Text] [Related]
5. The nonerythropoietic asialoerythropoietin protects against neonatal hypoxia-ischemia as potently as erythropoietin. Wang X; Zhu C; Wang X; Gerwien JG; Schrattenholz A; Sandberg M; Leist M; Blomgren K J Neurochem; 2004 Nov; 91(4):900-10. PubMed ID: 15525344 [TBL] [Abstract][Full Text] [Related]
6. Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure. Li Y; Takemura G; Okada H; Miyata S; Maruyama R; Li L; Higuchi M; Minatoguchi S; Fujiwara T; Fujiwara H Cardiovasc Res; 2006 Sep; 71(4):684-94. PubMed ID: 16828072 [TBL] [Abstract][Full Text] [Related]
7. The interaction between heart failure and other heart diseases, renal failure, and anemia. Silverberg DS; Wexler D; Iaina A; Schwartz D Semin Nephrol; 2006 Jul; 26(4):296-306. PubMed ID: 16949468 [TBL] [Abstract][Full Text] [Related]
8. Role of erythropoietin in anemia after heart transplantation. Gleissner CA; Klingenberg R; Staritz P; Koch A; Ehlermann P; Wiggenhauser A; Dengler TJ Int J Cardiol; 2006 Oct; 112(3):341-7. PubMed ID: 16309765 [TBL] [Abstract][Full Text] [Related]
9. Receptor binding of asialoerythropoietin. Dong YJ; Kung C; Goldwasser E J Cell Biochem; 1992 Mar; 48(3):269-76. PubMed ID: 1400613 [TBL] [Abstract][Full Text] [Related]
10. [Erythropoietin in the treatment of heart failure and ischemia]. Lewartowski B Kardiol Pol; 2007 Feb; 65(2):192-7. PubMed ID: 17366366 [No Abstract] [Full Text] [Related]
11. Erythropoietin and its derivative protect the intestine from severe ischemia/reperfusion injury in the rat. Mori S; Sawada T; Okada T; Kubota K Surgery; 2008 Apr; 143(4):556-65. PubMed ID: 18374054 [TBL] [Abstract][Full Text] [Related]
12. Renoprotective effects of asialoerythropoietin in diabetic mice against ischaemia-reperfusion-induced acute kidney injury. Nakazawa J; Isshiki K; Sugimoto T; Araki S; Kume S; Yokomaku Y; Chin-Kanasaki M; Sakaguchi M; Koya D; Haneda M; Kashiwagi A; Uzu T Nephrology (Carlton); 2010 Feb; 15(1):93-101. PubMed ID: 20377776 [TBL] [Abstract][Full Text] [Related]
13. The interaction between heart failure, renal failure and anemia - the cardio-renal anemia syndrome. Silverberg DS; Wexler D; Blum M; Wollman Y; Schwartz D; Sheps D; Keren G; Iaina A Blood Purif; 2004; 22(3):277-84. PubMed ID: 15166489 [TBL] [Abstract][Full Text] [Related]
14. Erythropoietin receptor is expressed on human peripheral blood T and B lymphocytes and monocytes and is modulated by recombinant human erythropoietin treatment. Lisowska KA; Debska-Slizień A; Bryl E; Rutkowski B; Witkowski JM Artif Organs; 2010 Aug; 34(8):654-62. PubMed ID: 20528849 [TBL] [Abstract][Full Text] [Related]
15. Preclinical evaluation of Hematide, a novel erythropoiesis stimulating agent, for the treatment of anemia. Fan Q; Leuther KK; Holmes CP; Fong KL; Zhang J; Velkovska S; Chen MJ; Mortensen RB; Leu K; Green JM; Schatz PJ; Woodburn KW Exp Hematol; 2006 Oct; 34(10):1303-11. PubMed ID: 16982323 [TBL] [Abstract][Full Text] [Related]
16. Erythropoietin: from molecular biology to clinical use. Lacombe C Eur Cytokine Netw; 1997 Sep; 8(3):308-10. PubMed ID: 9346370 [No Abstract] [Full Text] [Related]
17. Erythropoietin and its receptor in breast cancer: putting together the pieces of the puzzle. Mannello F; Tonti GA Oncologist; 2008 Jul; 13(7):761-8. PubMed ID: 18596367 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure. van der Putten K; Braam B; Jie KE; Gaillard CA Nat Clin Pract Nephrol; 2008 Jan; 4(1):47-57. PubMed ID: 18094727 [TBL] [Abstract][Full Text] [Related]